Nearly 2,000 drug plants are overdue for FDA checks after COVID delays, AP finds
U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected ...
US allows increased production of Takeda's ADHD drug and its generics to address shortage
The production limit for lisdexamfetamine was increased by 6,236 kilograms, which includes 1,558 kg to address increased ...
5 takeaways from AP’s report on the big backlog of uninspected drug factories
Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address ...
CEO Steps Down from Troubled Ecstasy-Drug Company
The leadership change comes after psychedelic drugmaker Lykos lost its bid for FDA approval.
COVID Delays Leave Nearly 2,000 Drug Plants Behind on Inspections: Report
The FDA has been backlogged in drug factory inspections since before the COVID-19 pandemic, a new report found.
FDA approved new COVID-19 vaccines. Here's what to know and where to get them
The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...
Live Science10h
Scientists just made mice 'see-through' using food dye — and humans are next
A common food dye can turn the skin of living mice transparent, but we don't yet know if it'll work in humans.
FDA drug-plant inspections still haven’t recovered from the pandemic, AP reports
Under FDA's own guidelines, drug factories that haven't been inspected in five or more years are considered a significant ...
Alaska Dispatch News4h
Nearly 2,000 drug plants are overdue for FDA checks after COVID delays
The firms that are overdue for safety and quality inspections represent about 42% of the 4,700 plants that are currently ...
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration
Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough ...
Nearly 2,000 drug manufacturing plants overdue for FDA inspections after COVID delays, AP finds
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...